1. Home
  2. KLTOW vs CNEY Comparison

KLTOW vs CNEY Comparison

Compare KLTOW & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • CNEY
  • Stock Information
  • Founded
  • KLTOW N/A
  • CNEY 2018
  • Country
  • KLTOW United States
  • CNEY China
  • Employees
  • KLTOW 3
  • CNEY N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • CNEY Major Chemicals
  • Sector
  • KLTOW Health Care
  • CNEY Industrials
  • Exchange
  • KLTOW Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • KLTOW N/A
  • CNEY 2.1M
  • IPO Year
  • KLTOW 2022
  • CNEY 2021
  • Fundamental
  • Price
  • KLTOW $0.24
  • CNEY $2.74
  • Analyst Decision
  • KLTOW
  • CNEY
  • Analyst Count
  • KLTOW 0
  • CNEY 0
  • Target Price
  • KLTOW N/A
  • CNEY N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • CNEY 49.8K
  • Earning Date
  • KLTOW N/A
  • CNEY 01-01-0001
  • Dividend Yield
  • KLTOW N/A
  • CNEY N/A
  • EPS Growth
  • KLTOW N/A
  • CNEY N/A
  • EPS
  • KLTOW N/A
  • CNEY N/A
  • Revenue
  • KLTOW N/A
  • CNEY $50,957,974.00
  • Revenue This Year
  • KLTOW N/A
  • CNEY N/A
  • Revenue Next Year
  • KLTOW N/A
  • CNEY N/A
  • P/E Ratio
  • KLTOW N/A
  • CNEY N/A
  • Revenue Growth
  • KLTOW N/A
  • CNEY N/A
  • 52 Week Low
  • KLTOW N/A
  • CNEY $2.53
  • 52 Week High
  • KLTOW N/A
  • CNEY $40.00
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • CNEY 42.93
  • Support Level
  • KLTOW N/A
  • CNEY $2.59
  • Resistance Level
  • KLTOW N/A
  • CNEY $2.84
  • Average True Range (ATR)
  • KLTOW 0.00
  • CNEY 0.17
  • MACD
  • KLTOW 0.00
  • CNEY 0.03
  • Stochastic Oscillator
  • KLTOW 0.00
  • CNEY 33.40

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: